Pediatric surgeon Michael La Quaglia worked with eighteen-year-old cancer survivor Elana Simon to identify a genetic abnormality that may be a cause of her cancer, called fibrolamellar hepatocellular carcinoma.
Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.
Irreversible electroporation – a new, minimally invasive treatment that uses electric current to poke tiny holes in cell membranes – is showing promise against hard-to-treat tumors.
Dr. D’Angelica – who treats patients with liver, pancreatic, and bile duct cancers – discusses the expertise of Memorial Sloan Kettering surgeons, who routinely perform complex procedures.